相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture
Suzanne M. Cadarette et al.
ANNALS OF INTERNAL MEDICINE (2008)
Systematic review: Comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis
Katrina E. Donahue et al.
ANNALS OF INTERNAL MEDICINE (2008)
The risk of infection associated with tumor necrosis factor alpha antagonists
Daniel H. Solomon et al.
ARTHRITIS AND RHEUMATISM (2008)
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
Kenneth G. Saag et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
DMARDS and infections in rheumatoid arthritis
Roberto Caporali et al.
AUTOIMMUNITY REVIEWS (2008)
Computerized definitions showed high positive predictive values for identifying hospitalizations for congestive heart failure and selected infections in Medicaid enrollees with rheumatoid arthritis
Carlos G. Grijalva et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
Changing patterns of medication use in patients with rheumatoid arthritis in a Medicaid population
C. G. Grijalva et al.
RHEUMATOLOGY (2008)
Assessment of adherence to and persistence on disease-modifying antirheumatic drugs (DMARDs) in patients with rheumatoid arthritis
Carlos G. Grijalva et al.
MEDICAL CARE (2007)
Serious infection following anti-tumor necrosis factor α therapy in patients with rheumatoid arthritis -: Lessons from interpreting data from observational studies
W. G. Dixon et al.
ARTHRITIS AND RHEUMATISM (2007)
Anti-tumor necrosis factor a therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis
Sebastian Schneeweiss et al.
ARTHRITIS AND RHEUMATISM (2007)
Veteran's affairs hospital discharge databases coded serious bacterial infections accurately
Sebastian Schneeweiss et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2007)
Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor α antagonists
Jeffrey R. Curtis et al.
ARTHRITIS AND RHEUMATISM (2007)
Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis
Daniel H. Solomon et al.
ARTHRITIS AND RHEUMATISM (2006)
Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy - Results from the British Society for Rheumatology Biologics Register
W. G. Dixon et al.
ARTHRITIS AND RHEUMATISM (2006)
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies - Systematic review and meta-analysis of rare harmful effects in randomized controlled trials
T Bongartz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics
Sebastian Schneeweiss
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2006)
Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia - Associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy
F Wolfe et al.
ARTHRITIS AND RHEUMATISM (2006)
The PREMIER study - A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
FC Breedveld et al.
ARTHRITIS AND RHEUMATISM (2006)
Infections in patients with rheumatoid arthritis treated with biologic agents
J Listing et al.
ARTHRITIS AND RHEUMATISM (2005)
Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy - A randomized, placebo-controlled, 52-week trial
EC Keystone et al.
ARTHRITIS AND RHEUMATISM (2004)
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial
L Klareskog et al.
LANCET (2004)
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis - A randomized, controlled trial
EWS Clair et al.
ARTHRITIS AND RHEUMATISM (2004)
Glucocorticoids in the treatment of early and late RA
JWJ Bijlsma et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk -: A multicenter active-surveillance report
JJ Gómez-Reino et al.
ARTHRITIS AND RHEUMATISM (2003)
Evaluating medication effects outside of clinical trials: New-user designs
WA Ray
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
Frequency of infection in patients with rheumatoid arthritis compared with controls - A population-based study
MF Doran et al.
ARTHRITIS AND RHEUMATISM (2002)
Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens:: current questions and tentative answers in rheumatology
F Buttgereit et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
Infliximab and methotrexate in the treatment of rheumatoid arthritis
PE Lipsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
